Items where Division is "03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Experimental Hematology (Skoda)"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Creators | Refereed
Jump to: 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2006
Number of items at this level: 28.


Hussein, K. and Percy, M. and McMullin, M. F. and Schwarz, J. and Schnittger, S. and Porret, N. and Martinez-Aviles, L. M. and Paricio, B. B. and Giraudier, S. and Skoda, R. and Lippert, E. and Hermouet, S. and Cario, H.. (2014) Clinical utility gene card for: Hereditary thrombocythemia. European journal of human genetics, Vol. 22, H. 2.


Girsberger, S. and Karow, A. and Lundberg, P. and Dirnhofer, S. and Lehmann, T. and Passweg, J. R. and Tichelli, A. and Skoda, R. and Rovo, A.. (2013) JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia : a case report. Acta haematologica, Vol. 129, H. 1. S. 23-25.

Grisouard, J. and Ojeda-Uribe, M. and Looser, R. and Hao-Shen, H. and Lundberg, P. and Duek, A. and Jeandidier, E. and Karow, A. and Skoda, R. C.. (2013) Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemia. Blood, Vol. 122, H. 22. S. 3694-3696.

Kubovcakova, L. and Lundberg, P. and Grisouard, J. and Hao-Shen, H. and Romanet, V. and Andraos, R. and Murakami, M. and Dirnhofer, S. and Wagner, K. U. and Radimerski, T. and Skoda, R. C.. (2013) Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model. Blood, Vol. 121, H. 7. S. 1188-1199.


Lai, Ching Janice. The DEAH helicase RHAU is essential for embryogenesis and hematopoiesis. 2012, PhD Thesis, University of Basel, Faculty of Science.

Lai, J. C. and Ponti, S. and Pan, D. and Kohler, H. and Skoda, R. C. and Matthias, P. and Nagamine, Y.. (2012) The DEAH-box helicase RHAU is an essential gene and critical for mouse hematopoiesis. Blood, Vol. 119, H. 18. S. 4291-4300.

de Wit, T. D. and Borkhardt, A. and Chomienne, C. and Dohner, H. and Fibbe, W. E. and Foa, R. and Hagenbeek, A. and Skoda, R. C. and Smand, C. R. and Jager, U.. (2012) Raising hematology's European voice: the importance of calling yourself a hematologist. Haematologica, Vol. 97, H. 4. S. 476-478.


Chagraoui, Hedia and Kassouf, Mira and Banerjee, Sreemoti and Goardon, Nicolas and Clark, Kevin and Atzberger, Ann and Pearce, Andrew C. and Skoda, Radek C. and Ferguson, David J. P. and Watson, Steve P. and Vyas, Paresh and Porcher, Catherine. (2011) SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis. Blood, Vol. 118, H. 3. S. 723-735.

Passamonti, Francesco and Elena, Chiara and Schnittger, Susanne and Skoda, Radek C. and Green, Anthony R. and Girodon, François and Kiladjian, Jean-Jacques and McMullin, Mary Frances and Ruggeri, Marco and Besses, Carles and Vannucchi, Alessandro M. and Lippert, Eric and Gisslinger, Heinz and Rumi, Elisa and Lehmann, Thomas and Ortmann, Christina A. and Pietra, Daniela and Pascutto, Cristiana and Haferlach, Torsten and Cazzola, Mario. (2011) Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood, Vol. 117, H. 10. S. 2813-2816.

Schaub, Franz X. and Lehmann, Thomas and Looser, Renate and Hao-Shen, Hui and Tichelli, Andre and Skoda, Radek C.. (2011) Transition to homozygosity does not appear to provide a clonal advantage to hematopoietic progenitors carrying mutations in TET2. Blood, Vol. 117, H. 6. S. 2075-2076.

Skoda, R. C. and Schwaller, J.. (2011) HiJAKing the methylosome in myeloproliferative disorders. Cancer cell, Vol. 19, H. 2. S. 161-163.

Ungureanu, Daniela and Wu, Jinhua and Pekkala, Tuija and Niranjan, Yashavanthi and Young, Clifford and Jensen, Ole N. and Xu, Chong-Feng and Neubert, Thomas A. and Skoda, Radek C. and Hubbard, Stevan R. and Silvennoinen, Olli. (2011) The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling. Nature structural & molecular biology, Vol. 18, no. 9. S. 971-976.

Zhang, G. and Xiang, B. and Dong, A. and Skoda, R. C. and Daugherty, A. and Smyth, S. S. and Du, X. and Li, Z.. (2011) Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation. Blood, Vol. 118, H. 13. S. 3670-3679.


Goldman, J. M. and Green, A. R. and Holyoake, T. and Jamieson, C. and Mesa, R. and Mughal, T. and Pellicano, F. and Perrotti, D. and Skoda, R. and Vannucchi, A. M.. (2009) Chronic myeloproliferative diseases with and without the Ph chromosome : some unresolved issues. Leukemia, Vol. 23, no. 10. S. 1708-1715.

Lippert, Eric and Girodon, François and Hammond, Emma and Jelinek, Jaroslav and Reading, N. Scott and Fehse, Boris and Hanlon, Katy and Hermans, Mirjam and Richard, Céline and Swierczek, Sabina and Ugo, Valérie and Carillo, Serge and Harrivel, Véronique and Marzac, Christophe and Pietra, Daniela and Sobas, Marta and Mounier, Morgane and Migeon, Marina and Ellard, Sian and Kröger, Nicolaus and Herrmann, Richard and Prchal, Josef T. and Skoda, Radek C. and Hermouet, Sylvie. (2009) Concordance of assays designed for the quantification of JAK2V617F : a multicenter study. Haematologica : journal of hematology, Vol. 94. S. 38-45.

Liu, Kun and Martini, Maurizio and Rocca, Bianca and Amos, Christopher I. and Teofili, Luciana and Giona, Fiorina and Ding, Jianmin and Komatsu, Hirokazu and Larocca, Luigi M. and Skoda, Radek C.. (2009) Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia. Haematologica : journal of hematology, Vol. 94. S. 1368-1374.

Medinger, Michael and Skoda, Radek and Gratwohl, Alois and Theocharides, Alexandre and Buser, Andreas and Heim, Dominik and Dirnhofer, Stephan and Tichelli, André and Tzankov, Alexandar. (2009) Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status. British journal of haematology, Vol. 146. S. 150-157.

Olcaydu, D. and Skoda, R. C. and Looser, R. and Li, S. and Cazzola, M. and Pietra, D. and Passamonti, F. and Lippert, E. and Carillo, S. and Girodon, F. and Vannucchi, A. and Reading, N. S. and Prchal, J. T. and Ay, C. and Pabinger, I. and Gisslinger, H. and Kralovics, R.. (2009) The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera. Leukemia, Vol. 23, no. 10. S. 1924-1926.

Schaub, Franz X. and Jäger, Roland and Looser, Renate and Hao-Shen, Hui and Hermouet, Sylvie and Girodon, François and Tichelli, Andre and Gisslinger, Heinz and Kralovics, Robert and Skoda, Radek C.. (2009) Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F. Blood : the journal of the American Society of Hematology, Vol. 113. S. 2022-2027.

Tefferi, Ayalew and Skoda, Radek and Vardiman, James W.. (2009) Myeloproliferative neoplasms : contemporary diagnosis using histology and genetics. Nature reviews . Clinical oncology, Vol. 6. S. 627-637.

Tiedt, Ralph and Coers, Jörn and Ziegler, Sandra and Wiestner, Adrian and Hao-Shen, Hui and Bornmann, Caroline and Schenkel, Johannes and Karakhanova, Svetlana and de Sauvage, Frederic J. and Jackson, Carl W. and Skoda, Radek C.. (2009) Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes. Blood : the journal of the American Society of Hematology, Vol. 113. S. 1768-1777.


Cross, N. C. P. and Daley, G. Q. and Green, A. R. and Hughes, T. P. and Jamieson, C. and Manley, P. and Mughal, T. and Perrotti, D. and Radich, J. and Skoda, R. and Soverini, S. and Vainchenker, W. and Verstovsek, S. and Villeval, J.-L. and Goldman, J. M.. (2008) BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders : some common and contrasting features. Leukemia, Vol. 22, no. 11. S. 1975-1989.

Langenkamp, Ulrich. Immunorecognition of leukemic stem cells by NK cells : the role of HDAC inhibitors in NKG2D ligand-mediated anti-tumor responses in acute myeloid leukemia. 2008, PhD Thesis, University of Basel, Faculty of Science.

Liu, K. and Kralovics, R. and Rudzki, Z. and Grabowska, B. and Buser, A. S. and Olcaydu, D. and Gisslinger, H. and Tiedt, R. and Frank, P. and Okoñ, K. and van der Maas, A. P. and Skoda, R. C.. (2008) A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family. Haematologica, Vol. 93, H. 5. S. 706-714.

Pasqualucci, L. and Li, S. and Meloni, G. and Schnittger, S. and Gattenlohner, S. and Liso, A. and Di Ianni, M. and Martelli, M. P. and Pescarmona, E. and Foa, R. and Haferlach, T. and Skoda, R. C. and Falini, B.. (2008) NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis : de-novo origin? Leukemia, Vol. 22, no. 7. S. 1459-1463.

Schmitt-Graeff, A. H. and Teo, S. S. and Olschewski, M. and Schaub, F. and Haxelmans, S. and Kirn, A. and Reinecke, P. and Germing, U. and Skoda, R. C.. (2008) JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Haematologica, Vol. 93, H. 1. S. 34-40.

Theocharides, A. and Passweg, J. R. and Medinger, M. and Looser, R. and Li, S. and Hao-Shen, H. and Buser, A. S. and Gratwohl, A. and Tichelli, A. and Skoda, R. C.. (2008) The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders. Haematologica, Vol. 93, H. 12. S. 1890-1893.


Schomber, Tibor. Transgenic models to study TGF-[beta] function in hematopoiesis. 2006, PhD Thesis, University of Basel, Faculty of Science.

This list was generated on Sat Mar 25 03:48:40 2017 CET.